Vontobel Holding’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-40,000
| Closed | -$920K | – | 1137 |
|
|
2023
Q1 | $920K | Hold |
40,000
| – | – | 0.01% | 610 |
|
|
2022
Q4 | $436K | Buy |
40,000
+10,000
| +33% | +$109K | ﹤0.01% | 792 |
|
|
2022
Q3 | $253K | Buy |
30,000
+10,000
| +50% | +$84.3K | ﹤0.01% | 896 |
|
|
2022
Q2 | $158K | Hold |
20,000
| – | – | ﹤0.01% | 965 |
|
|
2022
Q1 | $474K | Hold |
20,000
| – | – | ﹤0.01% | 808 |
|
|
2021
Q4 | $684K | Hold |
20,000
| – | – | 0.01% | 733 |
|
|
2021
Q3 | $354K | Buy |
20,000
+10,000
| +100% | +$177K | ﹤0.01% | 899 |
|
|
2021
Q2 | $449K | Hold |
10,000
| – | – | ﹤0.01% | 798 |
|
|
2021
Q1 | $259K | Buy |
+10,000
| New | +$259K | ﹤0.01% | 854 |
|